UCL’s ADAPT trial is testing a blood test for Alzheimer’s disease that measures p-tau217, aiming to raise diagnostic accuracy ...

Mandos Health® by Beren Therapeutics Public Benefit Corporation (P.B.C.) announced today that new analyses detailing the ...

Veteran pharmacy leader to advance Hercules’ strategy with operational excellence and AI-driven innovationPORT WASHINGTON, ...

JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”), a global specialty biopharmaceutical company dedicated to developing ...

Digi International (NASDAQ: DGII), a leading provider of secure connectivity solutions, today announced its newest IEC 60601 ...

Pete Pharma announced today a groundbreaking partnership with FABRX, the global pioneer of pharmaceutical 3D printing, to introduce this innovative technology to the U.S. compounding pharmacy ...

VANCOUVER, BC / ACCESS Newswire / September 12, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H)(WKN:A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company")is pleased to announce that its ...

The firm represented both buyer and seller in the acquisition of a 264,793-square-foot industrial facilityJANESVILLE, Wis.--(BUSINESS WIRE)--Please replace the release dated September 10, 2025 with ...

The "Global Photonic Quantum Computing Market 2026-2036" report has been added to ResearchAndMarkets.com's offering.The global photonic quantum computing market represents one of the most promising ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / September 12, 2025 / BioNxt Solutions Inc. ("BioNxt" or the ...

Results of the successful phase 3 TETON-2 study of inhaled treprostinil in idiopathic pulmonary fibrosis will be presented in an oral presentationSILVER SPRING, Md. & RESEARCH TRIANGLE PARK, ...

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the “Company” or ...